AAPL283.98+2.24 (+0.79%) ▲|ABBV252.87-1.44 (-0.57%) ▼|ABT92.35-0.36 (-0.39%) ▼|ACN123.06-1.68 (-1.35%) ▼|ADBE204.11-2.32 (-1.12%) ▼|AMAT719.79+25.15 (+3.62%) ▲|AMD549.63+10.14 (+1.88%) ▲|AMGN360.37-0.18 (-0.05%) ▼|AMT164.83-3.84 (-2.28%) ▼|AMZN239.40-0.74 (-0.31%) ▼|AVGO376.18+3.73 (+1.00%) ▲|AXP343.60+2.81 (+0.82%) ▲|BA216.23+1.56 (+0.73%) ▲|BAC57.18-0.70 (-1.20%) ▼|BKNG181.06-1.35 (-0.74%) ▼|BLK958.70+8.86 (+0.93%) ▲|BMY58.00-0.55 (-0.94%) ▼|BNY144.54+0.79 (+0.55%) ▲|BRK-B496.53+0.60 (+0.12%) ▲|C141.31-1.22 (-0.85%) ▼|CAT1,051.77+19.17 (+1.86%) ▲|CL91.64-0.74 (-0.80%) ▼|CMCSA24.82+0.60 (+2.48%) ▲|COF204.16+1.98 (+0.98%) ▲|COP103.92-0.28 (-0.27%) ▼|COST943.46-3.22 (-0.34%) ▼|CRM156.50-1.48 (-0.93%) ▼|CSCO118.07+0.37 (+0.31%) ▲|CVS102.99-0.59 (-0.57%) ▼|CVX167.91-0.56 (-0.33%) ▼|DE623.55-1.46 (-0.23%) ▼|DHR191.37-1.42 (-0.73%) ▼|DIS97.01-0.88 (-0.89%) ▼|DUK126.87-1.46 (-1.14%) ▼|EMR142.43-0.40 (-0.28%) ▼|FDX320.24-5.17 (-1.59%) ▼|GD349.21+1.14 (+0.33%) ▲|GE376.13+2.42 (+0.65%) ▲|GEV1,117.17+14.66 (+1.33%) ▲|GILD125.55-0.78 (-0.62%) ▼|GM77.01-0.33 (-0.43%) ▼|GOOG349.79-1.49 (-0.42%) ▼|GOOGL351.81-1.84 (-0.52%) ▼|GS1,016.28-3.93 (-0.39%) ▼|HD350.35-0.47 (-0.13%) ▼|HON227.26-0.54 (-0.24%) ▼|IBM275.70-2.30 (-0.83%) ▼|INTC134.85+3.13 (+2.38%) ▲|INTU264.76-1.65 (-0.62%) ▼|ISRG399.73-6.25 (-1.54%) ▼|JNJ256.53-1.99 (-0.77%) ▼|JPM328.55-0.85 (-0.26%) ▼|KO81.68-0.97 (-1.17%) ▼|LIN516.83+5.77 (+1.13%) ▲|LLY1,215.00-14.93 (-1.21%) ▼|LMT502.50+0.43 (+0.09%) ▲|LOW218.47-1.18 (-0.54%) ▼|LRCX433.07+22.16 (+5.39%) ▲|MA511.45+1.81 (+0.36%) ▲|MCD268.17+0.99 (+0.37%) ▲|MDLZ59.38-0.77 (-1.28%) ▼|MDT79.40-1.53 (-1.89%) ▼|META557.09-5.51 (-0.98%) ▼|MMM163.60+1.17 (+0.72%) ▲|MO73.47-0.58 (-0.78%) ▼|MRK128.38-1.01 (-0.78%) ▼|MS209.96-1.77 (-0.83%) ▼|MSFT372.00+3.43 (+0.93%) ▲|MU1,137.89-7.39 (-0.65%) ▼|NEE87.61-1.05 (-1.18%) ▼|NFLX73.43-0.35 (-0.47%) ▼|NKE41.16-0.32 (-0.77%) ▼|NOW98.42-1.56 (-1.56%) ▼|NVDA196.57+1.60 (+0.82%) ▲|ORCL148.27+0.51 (+0.35%) ▲|PEP138.38-0.30 (-0.22%) ▼|PFE24.11-0.26 (-1.08%) ▼|PG145.48-2.97 (-2.00%) ▼|PLTR116.19+0.49 (+0.42%) ▲|PM181.83-1.05 (-0.57%) ▼|QCOM187.09-1.63 (-0.86%) ▼|RTX189.04+1.71 (+0.91%) ▲|SBUX104.41+0.35 (+0.34%) ▲|SCHW93.24+2.69 (+2.97%) ▲|SO95.86-0.89 (-0.92%) ▼|SPG224.75-2.77 (-1.22%) ▼|T21.23-0.57 (-2.59%) ▼|TMO500.70-5.57 (-1.10%) ▼|TMUS169.11-4.87 (-2.80%) ▼|TSLA411.56-0.28 (-0.07%) ▼|TXN291.61+6.13 (+2.15%) ▲|UBER74.63-0.83 (-1.09%) ▼|UNH414.70-4.80 (-1.14%) ▼|UNP270.00-2.76 (-1.01%) ▼|UPS107.72-0.24 (-0.22%) ▼|USB60.67-0.59 (-0.96%) ▼|V341.34-0.35 (-0.10%) ▼|VZ43.06-1.01 (-2.30%) ▼|WFC83.26-0.24 (-0.29%) ▼|WMT113.92-0.68 (-0.59%) ▼|XOM135.63-0.41 (-0.30%) ▼|AAPL283.98+2.24 (+0.79%) ▲|ABBV252.87-1.44 (-0.57%) ▼|ABT92.35-0.36 (-0.39%) ▼|ACN123.06-1.68 (-1.35%) ▼|ADBE204.11-2.32 (-1.12%) ▼|AMAT719.79+25.15 (+3.62%) ▲|AMD549.63+10.14 (+1.88%) ▲|AMGN360.37-0.18 (-0.05%) ▼|AMT164.83-3.84 (-2.28%) ▼|AMZN239.40-0.74 (-0.31%) ▼|AVGO376.18+3.73 (+1.00%) ▲|AXP343.60+2.81 (+0.82%) ▲|BA216.23+1.56 (+0.73%) ▲|BAC57.18-0.70 (-1.20%) ▼|BKNG181.06-1.35 (-0.74%) ▼|BLK958.70+8.86 (+0.93%) ▲|BMY58.00-0.55 (-0.94%) ▼|BNY144.54+0.79 (+0.55%) ▲|BRK-B496.53+0.60 (+0.12%) ▲|C141.31-1.22 (-0.85%) ▼|CAT1,051.77+19.17 (+1.86%) ▲|CL91.64-0.74 (-0.80%) ▼|CMCSA24.82+0.60 (+2.48%) ▲|COF204.16+1.98 (+0.98%) ▲|COP103.92-0.28 (-0.27%) ▼|COST943.46-3.22 (-0.34%) ▼|CRM156.50-1.48 (-0.93%) ▼|CSCO118.07+0.37 (+0.31%) ▲|CVS102.99-0.59 (-0.57%) ▼|CVX167.91-0.56 (-0.33%) ▼|DE623.55-1.46 (-0.23%) ▼|DHR191.37-1.42 (-0.73%) ▼|DIS97.01-0.88 (-0.89%) ▼|DUK126.87-1.46 (-1.14%) ▼|EMR142.43-0.40 (-0.28%) ▼|FDX320.24-5.17 (-1.59%) ▼|GD349.21+1.14 (+0.33%) ▲|GE376.13+2.42 (+0.65%) ▲|GEV1,117.17+14.66 (+1.33%) ▲|GILD125.55-0.78 (-0.62%) ▼|GM77.01-0.33 (-0.43%) ▼|GOOG349.79-1.49 (-0.42%) ▼|GOOGL351.81-1.84 (-0.52%) ▼|GS1,016.28-3.93 (-0.39%) ▼|HD350.35-0.47 (-0.13%) ▼|HON227.26-0.54 (-0.24%) ▼|IBM275.70-2.30 (-0.83%) ▼|INTC134.85+3.13 (+2.38%) ▲|INTU264.76-1.65 (-0.62%) ▼|ISRG399.73-6.25 (-1.54%) ▼|JNJ256.53-1.99 (-0.77%) ▼|JPM328.55-0.85 (-0.26%) ▼|KO81.68-0.97 (-1.17%) ▼|LIN516.83+5.77 (+1.13%) ▲|LLY1,215.00-14.93 (-1.21%) ▼|LMT502.50+0.43 (+0.09%) ▲|LOW218.47-1.18 (-0.54%) ▼|LRCX433.07+22.16 (+5.39%) ▲|MA511.45+1.81 (+0.36%) ▲|MCD268.17+0.99 (+0.37%) ▲|MDLZ59.38-0.77 (-1.28%) ▼|MDT79.40-1.53 (-1.89%) ▼|META557.09-5.51 (-0.98%) ▼|MMM163.60+1.17 (+0.72%) ▲|MO73.47-0.58 (-0.78%) ▼|MRK128.38-1.01 (-0.78%) ▼|MS209.96-1.77 (-0.83%) ▼|MSFT372.00+3.43 (+0.93%) ▲|MU1,137.89-7.39 (-0.65%) ▼|NEE87.61-1.05 (-1.18%) ▼|NFLX73.43-0.35 (-0.47%) ▼|NKE41.16-0.32 (-0.77%) ▼|NOW98.42-1.56 (-1.56%) ▼|NVDA196.57+1.60 (+0.82%) ▲|ORCL148.27+0.51 (+0.35%) ▲|PEP138.38-0.30 (-0.22%) ▼|PFE24.11-0.26 (-1.08%) ▼|PG145.48-2.97 (-2.00%) ▼|PLTR116.19+0.49 (+0.42%) ▲|PM181.83-1.05 (-0.57%) ▼|QCOM187.09-1.63 (-0.86%) ▼|RTX189.04+1.71 (+0.91%) ▲|SBUX104.41+0.35 (+0.34%) ▲|SCHW93.24+2.69 (+2.97%) ▲|SO95.86-0.89 (-0.92%) ▼|SPG224.75-2.77 (-1.22%) ▼|T21.23-0.57 (-2.59%) ▼|TMO500.70-5.57 (-1.10%) ▼|TMUS169.11-4.87 (-2.80%) ▼|TSLA411.56-0.28 (-0.07%) ▼|TXN291.61+6.13 (+2.15%) ▲|UBER74.63-0.83 (-1.09%) ▼|UNH414.70-4.80 (-1.14%) ▼|UNP270.00-2.76 (-1.01%) ▼|UPS107.72-0.24 (-0.22%) ▼|USB60.67-0.59 (-0.96%) ▼|V341.34-0.35 (-0.10%) ▼|VZ43.06-1.01 (-2.30%) ▼|WFC83.26-0.24 (-0.29%) ▼|WMT113.92-0.68 (-0.59%) ▼|XOM135.63-0.41 (-0.30%) ▼|
28.8 C
New York
Tuesday, June 30, 2026

Tag: patient

newssourceFORcompanyinformationcontent1releasesmarket

HNL Lab Medicine Named Empowering Women Award Recipient for 2025

HNL Lab Medicine has been named a recipient of the 2025 Empowering Women Award by Lehigh Valley Business and Central Penn Business Journal.

OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation

OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation

HEALTHCARE COST TRANSPARENCY NOW AVAILABLE THROUGH NEW APP

Copay Technologies Helps New York Consumers Control Costs NEW YORK, July 9, 2025 /PRNewswire/ -- Copay Technologies today announced the official launch of Your...

Logistics Market Size Worth USD 23.14 Trillion by 2034 Driven by E-Commerce Growth, Tech Integration, and Government-Led Infrastructure Upgrades

The global logistics market size is expected to be worth approximately USD 23.14 trillion by 2034, increasing from USD 11.23 trillion in 2025, fueled by booming e-commerce, tech adoption, and infrastructure initiatives. 
The global logistics market size is expected to be worth approximately USD 23.14 trillion by 2034, increasing from USD 11.23 trillion in 2025, fueled by booming e-commerce, tech adoption, and infrastructure initiatives.

A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care

RIYADH, Saudi Arabia, July 09, 2025 (GLOBE NEWSWIRE) -- In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has continued to support a patient since infancy, providing 22 years of continuous care for a rare genetic blood clotting disorder, ultimately culminating in a liver transplant—the first of its kind globally for this particular condition.

RENEW Energy Partners Upgrades Mass General Brigham’s Energy Portfolio to Unlock Capital

RENEW upgrades MGB Spaulding Hospital's energy system, boosting efficiency by 10% and cutting costs, supporting their ESG goals with no upfront capital.

Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional registrational study and accelerating time to potential approval

SciBase Launches Nevisense Pilot at Leading University in Southeast Florida

STOCKHOLM, July 9, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that a private...

Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)

London – 9 July 2025 - Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, today announces that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for PS-002, enabling the initiation of a Phase I/II clinical trial in patients with primary IgA nephropathy (IgAN).

First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

SHANGHAI, July 9, 2025 /PRNewswire/ -- Duality Biotherapeutics' ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today...

First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

SHANGHAI, July 8, 2025 /PRNewswire/ -- Duality Biotherapeutics' ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today...

Yale School of Medicine Receives $27.7 Million Grant Toward Autism Research

NEW HAVEN, Conn., July 8, 2025 /PRNewswire-HISPANIC PR WIRE/ -- Yale School of Medicine (YSM) was awarded a $27.7 million grant from Aligning Research...

Yale School of Medicine Receives $27.7 Million Grant Toward Autism Research

NEW HAVEN, Conn., July 8, 2025 /PRNewswire/ -- Yale School of Medicine (YSM) was awarded a $27.7 million grant from Aligning Research to Impact...

Bispecifics/BiTE Market Anticipates Impressive Growth Trajectory During the Forecast Period (2025-2034) Across 7MM Due to Their Expansion Beyond Oncology | DelveInsight

The bispecific antibody and BiTE market is witnessing robust growth driven by advances in immuno-oncology and rising demand for targeted cancer therapies. Key factors...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers